Phase 1 Pharmacokinetics of Intravenous Nexium in Children
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate how much of repeated once daily intravenous
(IV, meaning through a vein) doses of esomeprazole gets into the bloodstream of hospitalized
children aged 0-17 years old that require acid suppression therapy.